Home / Ingredients / Oral glutathione
Bioavailability is formulation- and duration-dependent; biomarker changes are documented, but clinical health-outcome benefits remain uncertain.
Human studies have produced different findings. An older single-dose study found negligible systemic availability, while a 6-month randomized trial reported increased glutathione stores, and newer pharmacokinetic research suggests formulation-dependent absorption.
Dose, formulation, duration, and outcome matter. Raising a blood or tissue glutathione marker is not itself proof of a clinical benefit.
Short-term studies generally report tolerability, but the evidence base for long-term clinical outcomes and formulation-specific safety is limited.
V-GLUTATION lists glutathione but does not provide a dose or formulation specification on the current manufacturer page. Clinical benefit claims should remain under review.
Important: Ingredient-level evidence is not proof that a finished product has the same effect. Dose, form, population, duration, and formulation must match.
For informational purposes only; not individualized medical advice.